Nexgenia Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Nexgenia Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11064
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nexgenia Inc (Nexgenia) is a developer and manufacturer of proprietary polymer-based reagents. The company offers stimuli-responsive polymers and polymer-containing magnetic nanoparticles that develops speed, efficiency and sensitivity of molecular and cell separations for diagnostic and life science applications. Its magnetic nanoparticles perform cell separation on different cell types. Nexgenia’s technology is based on unique and proprietary families of stimuli-responsive smart polymers that change their state in response to small, discrete changes in their environment. The company serves diagnostic, pharmaceutical and biotech companies. Nexgenia is headquartered in Seattle, Washington, the US.

Nexgenia Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nexgenia Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nexgenia Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Nexgenia Raises USD0.12 Million in Venture Financing 10
Nexgenia Raises USD1.8 Million in Venture Financing 11
Nexgenia Raises USD1.6 Million in Financing Round 12
Nexgenia Raises USD0.5 Million in Seed Financing Round 13
Partnerships 14
Nexgenia Enters into Co-Development Agreement with Seattle Children’s Research Institute 14
Licensing Agreements 15
Nexgenia Enters into Licensing Agreement with CSIRO 15
Nexgenia Enters into Licensing Agreement with University of Washington 16
Nexgenia Inc – Key Competitors 17
Nexgenia Inc – Key Employees 18
Nexgenia Inc – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Nexgenia Inc, Pharmaceuticals & Healthcare, Key Facts 2
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nexgenia Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nexgenia Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nexgenia Raises USD0.12 Million in Venture Financing 10
Nexgenia Raises USD1.8 Million in Venture Financing 11
Nexgenia Raises USD1.6 Million in Financing Round 12
Nexgenia Raises USD0.5 Million in Seed Financing Round 13
Nexgenia Enters into Co-Development Agreement with Seattle Children’s Research Institute 14
Nexgenia Enters into Licensing Agreement with CSIRO 15
Nexgenia Enters into Licensing Agreement with University of Washington 16
Nexgenia Inc, Key Competitors 17
Nexgenia Inc, Key Employees 18

List of Figures
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nexgenia Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Nexgenia Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Trican Well Service Ltd. (TCW)-石油・ガス分野:企業M&A・提携分析
    Summary Trican Well Service Ltd. (Trican) is an oilfield services company, which provides a range of specialized products, equipment, services and technology for use in the drilling, completion, stimulation and reworking of oil and gas wells. Its specialized services comprise fracturing, cementing, …
  • Crrc Corporation Limited
    Crrc Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Crrc Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • The Cheesecake Factory Incorporated:企業の戦略・SWOT・財務情報
    The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report Summary The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • GS Yuasa Corporation:企業の戦略・SWOT・財務分析
    GS Yuasa Corporation - Strategy, SWOT and Corporate Finance Report Summary GS Yuasa Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Cal-Maine Foods Inc (CALM):企業の財務・戦略的SWOT分析
    Cal-Maine Foods Inc (CALM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • The British United Provident Association Limited:企業の戦略・SWOT・財務分析
    The British United Provident Association Limited - Strategy, SWOT and Corporate Finance Report Summary The British United Provident Association Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • A123 Systems LLC:企業の戦略的SWOT分析
    A123 Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Silver Peak Systems Inc:企業の戦略的SWOT分析
    Silver Peak Systems Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Sarepta Therapeutics Inc (SRPT):企業の財務・戦略的SWOT分析
    Sarepta Therapeutics Inc (SRPT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • IntelGenx Corp:企業のM&A・事業提携・投資動向
    IntelGenx Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IntelGenx Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Harman International Industries Inc:企業の戦略的SWOT分析
    Harman International Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Mitsubishi Tanabe Pharma Corporation:企業の戦略・SWOT・財務分析
    Mitsubishi Tanabe Pharma Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Tanabe Pharma Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Zymeworks Inc (ZYME):製薬・医療:M&Aディール及び事業提携情報
    Summary Zymeworks Inc (Zymeworks) is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of biotherapeutics for the treatment of cancer, autoimmune and inflammatory diseases. Its pipeline products include ZW25 and ZW49, novel bispecific antibodies …
  • Kolorfusion International Inc:企業の戦略的SWOT分析
    Kolorfusion International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • SoftTech Yazılım Teknolojileri Arastırma Gelistirme ve Pazarlama Ticaret A.S.:企業の戦略・SWOT・財務情報
    SoftTech Yazılım Teknolojileri Arastırma Gelistirme ve Pazarlama Ticaret A.S. - Strategy, SWOT and Corporate Finance Report Summary SoftTech Yazılım Teknolojileri Arastırma Gelistirme ve Pazarlama Ticaret A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data a …
  • Sanofi-Aventis Korea Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Sanofi-Aventis Korea Co Ltd (Sanofi-Aventis), a subsidiary of Sanofi is a developer, manufacturer and distributor of generic drugs and medical equipment. The company’s products include note vials lantus, lantus state solo star, she feeds the main vial la, feed her a solo star la shares, elro …
  • Ingram Entertainment Inc.:企業の戦略・SWOT・財務情報
    Ingram Entertainment Inc. - Strategy, SWOT and Corporate Finance Report Summary Ingram Entertainment Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Metso Corporation:企業の戦略・SWOT・財務分析
    Metso Corporation - Strategy, SWOT and Corporate Finance Report Summary Metso Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Einstein Noah Restaurant Group, Inc. (Foodservice):戦略・SWOT・企業財務分析
    Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Extendicare Inc.:企業の戦略・SWOT・財務情報
    Extendicare Inc. - Strategy, SWOT and Corporate Finance Report Summary Extendicare Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆